skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 2,509  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Vaccines remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Nanomaterial Delivery Systems for mRNA Vaccines
Material Type:
Article
Add to My Research

Nanomaterial Delivery Systems for mRNA Vaccines

Vaccines (Basel), 2021-01, Vol.9 (1), p.65 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9010065 ;PMID: 33478109

Full text available

2
Efforts at COVID-19 Vaccine Development: Challenges and Successes
Material Type:
Article
Add to My Research

Efforts at COVID-19 Vaccine Development: Challenges and Successes

Vaccines (Basel), 2020-12, Vol.8 (4), p.739 [Peer Reviewed Journal]

2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines8040739 ;PMID: 33291245

Full text available

3
Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines
Material Type:
Article
Add to My Research

Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines

Vaccines (Basel), 2021-09, Vol.9 (9), p.1033 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9091033 ;PMID: 34579270

Full text available

4
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination
Material Type:
Article
Add to My Research

Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination

Vaccines (Basel), 2021-04, Vol.9 (5), p.435 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9050435 ;PMID: 33946748

Full text available

5
Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
Material Type:
Article
Add to My Research

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

Vaccines (Basel), 2022-01, Vol.10 (1), p.86 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10010086 ;PMID: 35062747

Full text available

6
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
Material Type:
Article
Add to My Research

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19

Vaccines (Basel), 2021-03, Vol.9 (3), p.243 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9030243 ;PMID: 33799505

Full text available

7
Progress and Prospects on Vaccine Development against SARS-CoV-2
Material Type:
Article
Add to My Research

Progress and Prospects on Vaccine Development against SARS-CoV-2

Vaccines (Basel), 2020-03, Vol.8 (2), p.153 [Peer Reviewed Journal]

2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines8020153 ;PMID: 32235387

Full text available

8
Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia
Material Type:
Article
Add to My Research

Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia

Vaccines (Basel), 2021-06, Vol.9 (6), p.674 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9060674 ;PMID: 34207394

Full text available

9
Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
Material Type:
Article
Add to My Research

Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm

Vaccines (Basel), 2021-04, Vol.9 (5), p.436 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9050436 ;PMID: 33946736

Full text available

10
Attitude and Behaviors towards SARS-CoV-2 Vaccination among Healthcare Workers: A Cross-Sectional Study from Poland
Material Type:
Article
Add to My Research

Attitude and Behaviors towards SARS-CoV-2 Vaccination among Healthcare Workers: A Cross-Sectional Study from Poland

Vaccines (Basel), 2021-03, Vol.9 (3), p.218 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9030218 ;PMID: 33806641

Full text available

11
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
Material Type:
Article
Add to My Research

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers

Vaccines (Basel), 2021-09, Vol.9 (10), p.1092 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9101092 ;PMID: 34696200

Full text available

12
Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
Material Type:
Article
Add to My Research

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland

Vaccines (Basel), 2021-11, Vol.9 (11), p.1286 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9111286 ;PMID: 34835217

Full text available

13
COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study
Material Type:
Article
Add to My Research

COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study

Vaccines (Basel), 2021-12, Vol.9 (12), p.1437 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9121437 ;PMID: 34960183

Full text available

14
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Material Type:
Article
Add to My Research

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy

Vaccines (Basel), 2021-10, Vol.9 (10), p.1195 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9101195 ;PMID: 34696303

Full text available

15
Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey
Material Type:
Article
Add to My Research

Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey

Vaccines (Basel), 2020-11, Vol.8 (4), p.711 [Peer Reviewed Journal]

2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines8040711 ;PMID: 33266212

Full text available

16
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Material Type:
Article
Add to My Research

Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences

Vaccines (Basel), 2022-06, Vol.10 (6), p.919 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10060919 ;PMID: 35746526

Full text available

17
Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
Material Type:
Article
Add to My Research

Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2

Vaccines (Basel), 2021-06, Vol.9 (6), p.572 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9060572 ;PMID: 34205861

Full text available

18
Medical Students and SARS-CoV-2 Vaccination: Attitude and Behaviors
Material Type:
Article
Add to My Research

Medical Students and SARS-CoV-2 Vaccination: Attitude and Behaviors

Vaccines (Basel), 2021-02, Vol.9 (2), p.128 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9020128 ;PMID: 33562872

Full text available

19
Comparison of Four SARS-CoV-2 Neutralization Assays
Material Type:
Article
Add to My Research

Comparison of Four SARS-CoV-2 Neutralization Assays

Vaccines (Basel), 2020-12, Vol.9 (1), p.13 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9010013 ;PMID: 33379160

Full text available

20
COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
Material Type:
Article
Add to My Research

COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly

Vaccines (Basel), 2021-11, Vol.9 (11), p.1299 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9111299 ;PMID: 34835230

Full text available

Results 1 - 20 of 2,509  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait